Steve Brozak holds a BA from Columbia University, an MBA from Columbia Business School, and a Doctor of Medical Humanities from Drew University. He is the President and co-founder of WBB Securities, LLC, where he has focused on healthcare, biotechnology, pharmaceutical, and medical device research and banking. Brozak has also served as Chairman and CEO of StormBio, Inc., specializing in cytokine storm attenuation, particularly in influenza. His expertise spans human stem cell therapies, biothreat countermeasures, and highly pathogenic influenza. Brozak has contributed to various media outlets and produced films on economic and veteran issues.

Steve Brozak’s multifaceted background in finance, biotechnology, and media uniquely positions him to blend economic and health policy insights. His advocacy for restructuring the FDA and addressing pharmaceutical challenges reveals a strategic focus on the intersection of healthcare and economic stability. Brozak’s commentary on the Fukushima disaster and his analytical reports on pandemic influenza showcase a forward-thinking approach to public health crises, combining scientific expertise with a nuanced understanding of global impacts. This convergence of policy areas suggests an ideologically agile thinker, adept at navigating complex, multi-disciplinary challenges.